Results 81 to 90 of about 1,489,445 (215)

Prehospital diagnostic acute pericarditis [PDF]

open access: yes, 2016
Introduction: Chest pain is a common issue in the differential diagnosis prehospital emergency work. It may be a sign of serious life-threatening diseases such as acute coronary syndrome, aortic dissection, pulmonary embolism and acute pneumothorax.
Milutinović Vladimir   +1 more
core   +1 more source

Current and emerging strategies for the treatment of acute pericarditis: a systematic review

open access: yes, 2010
Samar Sheth1, Dee Dee Wang3, Christos Kasapis21Department of Internal Medicine, 2Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, MI, USA; 3Henry Ford Hospital, Division of Cardiovascular Medicine, Detroit, MI, USAAbstract ...
Christos Kasapis   +4 more
core   +1 more source

Cardiovascular Toxicity Associated With Bispecific Antibodies in Hematological Malignancies: A Comprehensive Pharmacovigilance Analysis

open access: yesAmerican Journal of Hematology, Volume 101, Issue 10, Page 2546-2556, October 2026.
ABSTRACT Cardiovascular adverse events (CVAEs) associated with bispecific T‐cell engaging antibodies (BsAbs) have not been systematically investigated across approved agents. In this disproportionality analysis of FAERS (December 2014–September 2025), reports listing BsAbs as the primary suspected drug (n = 7647) were compared with all other drugs in ...
Malak Munir   +9 more
wiley   +1 more source

Pericarditis Epistenocardica or Dressler Syndrome? An Autopsy Case

open access: yesCase Reports in Medicine, 2015
Postinfarction pericarditis can be classified as “early,” referred to as pericarditis epistenocardica, or “delayed,” referred to as Dressler syndrome. The incidence of postinfarction pericarditis has decreased to
Alessandro Feola   +2 more
doaj   +1 more source

Simultaneous 3‐D Adiabatic T1ρ, T2*, and Quantitative Susceptibility Mapping for Characterization of Myocardial Infarction in Ex Vivo Mouse

open access: yesNMR in Biomedicine, Volume 39, Issue 10, October 2026.
This study combines segmented T1ρ preparation into a 3‐D gradient‐echo sequence for simultaneous quantitative susceptibility, T2*, and T1ρ mapping of infarcted mouse hearts ex vivo. The method enabled assessment of T1ρ and T2* relaxation time maps and magnetic susceptibility, with ischemic regions clearly identified by all contrasts and consistent with
Iida Räty   +6 more
wiley   +1 more source

Age- and sex-based differences in patients with acute pericarditis

open access: yes, 2021
Background: Acute pericarditis has a wide spectrum of clinical presentations largely depending on underlying aetiologies. We assessed the role of age and sex in the clinical features and outcome of acute pericarditis.
Tousoulis, D.   +6 more
core   +1 more source

Expanding the Patient Pool for Rilonacept

open access: yesJACC: Case Reports
Recurrent pericarditis complicates 15%-30% of acute pericarditis cases despite initial anti-inflammatory treatment. The RHAPSODY trial (Study to Assess the Efficacy and Safety of Rilonacept Treatment in Participants With Recurrent Pericarditis) showed ...
Emma St. John, MD   +9 more
doaj   +1 more source

An unusual cause of acute constrictive pericarditis

open access: yes
Constrictive pericarditis, a condition where the pericardium thickens and constricts, has long been considered as a chronic sequela of prior insults to the pericardium such as heart surgery, repeated pericarditis, tuberculosis infection, radiation ...
Tang, Yue Hin, Fung, Raymond Chi Yan
core   +1 more source

Acute pericarditis and pleural effusion complicating cytarabine chemotherapy.

open access: yes, 2003
BACKGROUND Pericarditis is a rare but possibly severe complication of treatment of acute leukemia with cytarabine. CASE REPORT We report a possibly cytarabine-induced acute pericarditis and pleuritis with a rapid onset.
Hess U, Gähler A, Hitz F, Cerny T
core   +1 more source

Efficacy and Safety of Once‐Weekly Semaglutide 2.0 mg as an Add‐On to Dose‐Reduced Insulin Glargine versus Dose‐Titrated Insulin Glargine in People With Type 2 Diabetes and Overweight (SUSTAIN OPTIMIZE)

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 10, Page 9304-9316, October 2026.
ABSTRACT Aims Type 2 diabetes (T2D) management with basal insulin can lead to hypoglycaemia and weight gain. SUSTAIN OPTIMIZE compared once‐weekly semaglutide 2.0 mg as add‐on to dose‐reduced insulin glargine (Sema+IGlarreduced) versus dose‐titrated IGlar (IGlartitrated) on glycated haemoglobin (HbA1c), body weight (BW), daily insulin dose, and ...
Helena W. Rodbard   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy